Eli Lilly ends antibody study after hospitalized COVID-19 patients show little gain
Indianapolis-based Eli Lilly and Co. gives an update on third-quarter earnings. |!| Indianapolis
Indianapolis-based Eli Lilly and Co. gives an update on third-quarter earnings. |!| Indianapolis